Works by Motomura, Kenta

Results: 33

Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 249, doi. 10.1159/000514420

By:

Kudo, Masatoshi;
Motomura, Kenta;
Wada, Yoshiyuki;
Inaba, Yoshitaka;
Sakamoto, Yasunari;
Kurosaki, Masayuki;
Umeyama, Yoshiko;
Kamei, Yoichi;
Yoshimitsu, Junichiro;
Fujii, Yosuke;
Aizawa, Mana;
Robbins, Paul B.;
Furuse, Junji

Publication type:

Article

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.

Published in:

2021

By:

Zhu, Andrew X.;
Finn, Richard S.;
Kang, Yoon-Koo;
Yen, Chia-Jui;
Galle, Peter R.;
Llovet, Josep M.;
Assenat, Eric;
Brandi, Giovanni;
Motomura, Kenta;
Ohno, Izumi;
Daniele, Bruno;
Vogel, Arndt;
Yamashita, Tatsuya;
Hsu, Chih-Hung;
Gerken, Guido;
Bilbruck, John;
Hsu, Yanzhi;
Liang, Kun;
Widau, Ryan C.;
Wang, Chunxiao

Publication type:

journal article

A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma.

Published in:

Cancer Science, 2020, v. 111, n. 10, p. 3759, doi. 10.1111/cas.14582

By:

Kudo, Masatoshi;
Morimoto, Manabu;
Moriguchi, Michihisa;
Izumi, Namiki;
Takayama, Tetsuji;
Yoshiji, Hitoshi;
Hino, Keisuke;
Oikawa, Takayoshi;
Chiba, Tetsuhiro;
Motomura, Kenta;
Kato, Junko;
Yasuchika, Kentaro;
Ido, Akio;
Sato, Takashi;
Nakashima, Daisuke;
Ueshima, Kazuomi;
Ikeda, Masafumi;
Okusaka, Takuji;
Tamura, Kazuo;
Furuse, Junji

Publication type:

Article

Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response.

Published in:

Journal of Gastroenterology & Hepatology, 2001, v. 16, n. 1, p. 29, doi. 10.1046/j.1440-1746.2001.02390.x

By:

Nakamuta, M;
Nakamuta, Makoto;
Fukutomi, Takayoshi;
Shimohashi, Naoya;
Kinukawa, Naoko;
Uchimura, Koutaro;
Tada, Seiya;
Motomura, Kenta;
Enjoji, Munechika;
Kato, Masaki;
Iwamoto, Hiroaki;
Tanabe, Yuichi;
Imari, Yasuhisa;
Sakamoto, Shigeru;
Sakai, Hironori;
Nawata, Hajime

Publication type:

Article

All- trans retinoic acid suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats.

Published in:

Journal of Gastroenterology & Hepatology, 1997, v. 12, n. 12, p. 887, doi. 10.1111/j.1440-1746.1997.tb00388.x

By:

MOTOMURA, KENTA;
SAKAI, HIRONORI;
ISOBE, HIDEHIKO;
NAWATA, HAJIME

Publication type:

Article

CASE REPORT: Haemothorax due to hepatocellular carcinoma rupture successfully controlled by transcatheter arterial embolization.

Published in:

Journal of Gastroenterology & Hepatology, 1997, v. 12, n. 2, p. 156, doi. 10.1111/j.1440-1746.1997.tb00399.x

By:

MASUMOTO, AKIHIDE;
MOTOMURA, KENTA;
UCHIMURA, KOUTARO;
MOROTOMI, IKUO;
MORITA, KAZUNORI

Publication type:

Article

Risk factors for loss to follow‐up after the start of direct‐acting antiviral treatment for hepatitis C virus infection.

Published in:

JGH Open, 2023, v. 7, n. 2, p. 98, doi. 10.1002/jgh3.12855

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Kurosaka, Kazuki;
Tanaka, Kosuke;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan.

Published in:

Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 195, doi. 10.1007/s40801-022-00348-w

By:

Furuse, Junji;
Izumi, Namiki;
Motomura, Kenta;
Inaba, Yoshitaka;
Katamura, Yoshio;
Kondo, Yasuteru;
Yabushita, Kazuhisa;
Motoyoshi, Katsuaki;
Kudo, Masatoshi

Publication type:

Article

Photosensitivity and Acute Liver Insufficiency in Late-Onset Erythropoietic Protoporphyria with a Chromosome 18q Abnormality.

Published in:

Case Reports in Dermatology, 2012, v. 4, n. 2, p. 144, doi. 10.1159/000341111

By:

Oshikawa, Yuka;
Fukushima, Satoshi;
Miyake, Taiga;
Kawaguchi, Takeshi;
Motomura, Kenta;
Nakashima, Yasuhiro;
Nakamura, Kenichi;
Jinnin, Masatoshi;
Ihn, Hironobu

Publication type:

Article

Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenib.

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 543, doi. 10.1111/jvh.13681

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Nagasawa, Shigehiro;
Tanaka, Kosuke;
Morita, Yusuke;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment.

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 1, p. 35, doi. 10.1111/jvh.13625

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Nagasawa, Shigehiro;
Tanaka, Kosuke;
Morita, Yusuke;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study.

Published in:

In Vivo, 2024, v. 38, n. 4, p. 1854, doi. 10.21873/invivo.13639

By:

AKIFUMI KUWANO;
MASAYOSHI YADA;
KOSUKE TANAKA;
YUTA KOGA;
SHIGEHIRO NAGASAWA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study.

Published in:

Journal of Gastroenterology, 2021, v. 56, n. 2, p. 181, doi. 10.1007/s00535-020-01753-0

By:

Kudo, Masatoshi;
Tsuchiya, Kaoru;
Kato, Naoya;
Hagihara, Atsushi;
Numata, Kazushi;
Aikata, Hiroshi;
Inaba, Yoshitaka;
Kondo, Shunsuke;
Motomura, Kenta;
Furuse, Junji;
Ikeda, Masafumi;
Morimoto, Manabu;
Achira, Meguru;
Kuroda, Shingo;
Kimura, Akiko

Publication type:

Article

Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.

Published in:

2020

By:

Kudo, Masatoshi;
Okusaka, Takuji;
Motomura, Kenta;
Ohno, Izumi;
Morimoto, Manabu;
Seo, Satoru;
Wada, Yoshiyuki;
Sato, Shinpei;
Yamashita, Tatsuya;
Furukawa, Masayuki;
Aramaki, Takeshi;
Nadano, Seijin;
Ohkawa, Kazuyoshi;
Fujii, Hirofumi;
Kudo, Toshihiro;
Furuse, Junji;
Takai, Hiroki;
Homma, Gosuke;
Yoshikawa, Reigetsu;
Zhu, Andrew X.

Publication type:

journal article

Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2.

Published in:

Liver International, 2020, v. 40, n. 8, p. 2008, doi. 10.1111/liv.14462

By:

Kudo, Masatoshi;
Galle, Peter R.;
Llovet, Josep M.;
Finn, Richard S.;
Vogel, Arndt;
Motomura, Kenta;
Assenat, Eric;
Merle, Philippe;
Brandi, Giovanni;
Daniele, Bruno;
Okusaka, Takuji;
Tomášek, Jiří;
Borg, Christophe;
Dadduzio, Vincenzo;
Morimoto, Manabu;
Pracht, Marc;
Jen, Min‐Hua;
Drove Ubreva, Nora;
Widau, Ryan C.;
Shinozaki, Kenta

Publication type:

Article

Prognostic Significance of Lymphocyte-to-Monocyte Ratio in Patients With Unresectable Biliary Tract Cancer Undergoing Systemic Chemotherapy.

Published in:

Cancer Diagnosis & Prognosis, 2025, v. 5, n. 1, p. 132, doi. 10.21873/cdp.10422

By:

HIDEO SUZUKI;
AKIFUMI KUWANO;
JUNRO TAKAHIRA;
KOSUKE TANAKA;
MASAYOSHI YADA;
KENTA MOTOMURA

Publication type:

Article

Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class B.

Published in:

Cancer Diagnosis & Prognosis, 2024, v. 4, n. 2, p. 111, doi. 10.21873/cdp.10295

By:

AKIFUMI KUWANO;
MASAYOSHI YADA;
KOSUKE TANAKA;
YUTA KOGA;
SHIGEHIRO NAGASAWA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Published in:

Cancer Diagnosis & Prognosis, 2024, v. 4, n. 1, p. 34, doi. 10.21873/cdp.10282

By:

AKIFUMI KUWANO;
MASAYOSHI YADA;
KOSUKE TANAKA;
YUTA KOGA;
SHIGEHIRO NAGASAWA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Combined Ultrasound and Computed Tomography Guidance in Radiofrequency Ablation for Hepatocellular Carcinoma Reduces Local Recurrence Rate.

Published in:

Cancer Diagnosis & Prognosis, 2023, v. 3, n. 6, p. 660, doi. 10.21873/cdp.10269

By:

SHIGEHIRO NAGASAWA;
AKIFUMI KUWANO;
KOSUKE TANAKA;
MASAYOSHI YADA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Published in:

Cancer Diagnosis & Prognosis, 2023, v. 3, n. 4, p. 468, doi. 10.21873/cdp.10241

By:

AKIFUMI KUWANO;
MASAYOSHI YADA;
YOSHIKO MIYAZAKI;
KOSUKE TANAKA;
YUTA KOGA;
YOSHIHIRO OHISHI;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Tumor‐infiltrating CD8<sup>+</sup> T‐cell numbers and serum C‐reactive protein levels as a prognostic biomarker in hepatocellular carcinoma patients receiving atezolizumab plus bevacizumab.

Published in:

Hepatology Research, 2025, v. 55, n. 4, p. 600, doi. 10.1111/hepr.14157

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Tanaka, Kosuke;
Takahira, Junro;
Suzuki, Hideo;
Ohishi, Yoshihiro;
Motomura, Kenta

Publication type:

Article

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 409, doi. 10.1111/hepr.13876

By:

Kato, Naoya;
Kudo, Masatoshi;
Tsuchiya, Kaoru;
Hagihara, Atsushi;
Numata, Kazushi;
Aikata, Hiroshi;
Inaba, Yoshitaka;
Kondo, Shunsuke;
Motomura, Kenta;
Okano, Naohiro;
Ikeda, Masafumi;
Morimoto, Manabu;
Kuroda, Shingo;
Kimura, Akiko

Publication type:

Article

Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β-catenin signal activation.

Published in:

Oncology Letters, 2022, v. 24, n. 1, p. N.PAG, doi. 10.3892/ol.2022.13337

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Narutomi, Fumiya;
Nagasawa, Shigehiro;
Tanaka, Kosuke;
Kurosaka, Kazuki;
Ohishi, Yoshihiro;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI.

Published in:

Molecular & Clinical Oncology, 2022, v. 16, n. 2, p. 1, doi. 10.3892/mco.2021.2486

By:

AKIFUMI KUWANO;
KOSUKE TANAKA;
MASAYOSHI YADA;
SHIGEHIRO NAGASAWA;
YUSUKE MORITA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

Diagnostic features of autoimmune hepatitis in SARS-CoV-2-vaccinated vs. unvaccinated individuals.

Published in:

Experimental & Therapeutic Medicine, 2024, v. 28, n. 3, p. 1, doi. 10.3892/etm.2024.12626

By:

AKIFUMI KUWANO;
SHIGEHIRO NAGASAWA;
YUTA KOGA;
KOSUKE TANAKA;
MASAYOSHI YADA;
AKIHIDE MASUMOTO;
KENTA MOTOMURA

Publication type:

Article

FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy.

Published in:

Experimental & Therapeutic Medicine, 2023, v. 26, n. 3, p. N.PAG, doi. 10.3892/etm.2023.12140

By:

Kuwano, Akifumi;
Miyazaki, Masayuki;
Yada, Masayoshi;
Tanaka, Kosuke;
Koga, Yuta;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice.

Published in:

Cancers, 2025, v. 17, n. 3, p. 479, doi. 10.3390/cancers17030479

By:

Furuse, Junji;
Izumi, Namiki;
Motomura, Kenta;
Inaba, Yoshitaka;
Katamura, Yoshio;
Kondo, Yasuteru;
Yabushita, Kazuhisa;
Matsuoka, Toshiyuki;
Motoyoshi, Katsuaki;
Kudo, Masatoshi

Publication type:

Article

Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice.

Published in:

Cancers, 2023, v. 15, n. 17, p. 4345, doi. 10.3390/cancers15174345

By:

Motomura, Kenta;
Kuwano, Akifumi;
Tanaka, Kosuke;
Koga, Yuta;
Masumoto, Akihide;
Yada, Masayoshi

Publication type:

Article

Word Decoding of Protein Amino Acid Sequences with Availability Analysis: A Linguistic Approach.

Published in:

PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0050039

By:

Motomura, Kenta;
Fujita, Tomohiro;
Tsutsumi, Motosuke;
Kikuzato, Satsuki;
Nakamura, Morikazu;
Otaki, Joji M.

Publication type:

Article

Dynamics of the neutrophil‑to‑lymphocyte ratio during lenvatinib treatment for unresectable hepatocellular carcinoma.

Published in:

Oncology Letters, 2024, v. 28, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14442

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Koga, Yuta;
Tanaka, Kosuke;
Ohishi, Yoshihiro;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Tumor‑infiltrating CD8<sup>+</sup> T cells as a biomarker for chemotherapy efficacy in unresectable hepatocellular carcinoma.

Published in:

Oncology Letters, 2023, v. 25, n. 6, p. N.PAG, doi. 10.3892/ol.2023.13845

By:

Kuwano, Akifumi;
Yada, Masayoshi;
Miyazaki, Yoshiko;
Tanaka, Kosuke;
Kurosaka, Kazuki;
Ohishi, Yoshihiro;
Masumoto, Akihide;
Motomura, Kenta

Publication type:

Article

Effects of retinoids on the production of tumour necrosis factor-alpha and nitric oxide by lipopolysaccharide-stimulated rat Kupffer cells in vitro: evidence for participation of retinoid X receptor signalling pathway.

Published in:

Cell Biochemistry & Function, 1997, v. 15, n. 2, p. 95, doi. 10.1002/(SICI)1099-0844(19970601)15:2<95::AID-CBF727>3.0.CO;2-8

By:

Motomura, Kenta;
Sakai, Hironori;
Isobe, Hidehiko;
Nawata, Hajime

Publication type:

Article

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma.

Published in:

Internal Medicine, 2022, v. 61, n. 21, p. 3157, doi. 10.2169/internalmedicine.9237-21

By:

Rie Sugimoto;
Kenta Motomura;
Aritsune Ooho;
Yoshifusa Aratake;
Akihiro Ueda;
Takeshi Senju;
Yuki Tanaka;
Masayoshi Yada;
Kohsuke Tanaka;
Akifumi Kuwano;
Yuusuke Morita;
Shigehiro Nagasawa;
Mari Ooe;
Taiji Mutsuki;
Tsuyoshi Yoshimoto;
Naoki Yamashita;
Mai Nakashima;
Tomonobu Hioki;
Toshimasa Koyanagi;
Nobito Higuchi

Publication type:

Article